UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Emerging infectious diseases, ISSN 1080-6040, 2009, Volume 15, Issue 4, pp. 552 - 560
Antiviral Agents - pharmacology | Influenza A Virus, H1N1 Subtype - classification | Hemagglutinins, Viral - genetics | Humans | Enzyme Inhibitors - pharmacology | Europe - epidemiology | Neuraminidase - genetics | Influenza, Human - epidemiology | Communicable Diseases, Emerging - epidemiology | Phylogeny | Influenza A Virus, H1N1 Subtype - drug effects | Drug Resistance, Viral - genetics | Influenza A Virus, H1N1 Subtype - enzymology | Genes, Viral | Communicable Diseases, Emerging - drug therapy | Influenza, Human - virology | Neuraminidase - antagonists & inhibitors | Influenza, Human - drug therapy | Mutation | Seasons | Communicable Diseases, Emerging - virology | Influenza A Virus, H1N1 Subtype - genetics | Oseltamivir - pharmacology | Population Surveillance - methods | Influenza viruses | Causes of | Research | Health aspects | Influenza | Distribution | Index Medicus | Life Sciences | Biochemistry, Molecular Biology
Journal Article
Nature (London), ISSN 0028-0836, 08/2009, Volume 460, Issue 7258, pp. 1021 - 1025
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Fundamental and applied biological sciences. Psychology | Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains | Antiviral agents | Microbiology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Virology | Antibiotics. Antiinfectious agents. Antiparasitic agents | Macaca fascicularis - immunology | Swine Diseases - virology | Humans | Influenza A Virus, H1N1 Subtype - physiology | Male | Neutralization Tests | Ferrets - virology | Swine, Miniature - virology | Lung - virology | Primate Diseases - pathology | Female | Cell Line | Antiviral Agents - pharmacology | Lung - pathology | Swine Diseases - pathology | Influenza A Virus, H1N1 Subtype - pathogenicity | HN Protein - metabolism | Influenza A Virus, H1N1 Subtype - drug effects | Primate Diseases - virology | Animals | Orthomyxoviridae Infections - transmission | Virus Replication | Influenza A Virus, H1N1 Subtype - enzymology | Dogs | Antibodies, Viral - immunology | Mice | Mice, Inbred BALB C | Orthomyxoviridae Infections - virology | Swine - virology | Lung - immunology | Macaca fascicularis - virology | Orthomyxoviridae Infections - immunology | Influenza viruses | Genetic aspects | Properties | Swine influenza | Scanning electron microscopy | Cytokines | Swine flu | Influenza | Viruses | Avian flu | Index Medicus
Journal Article
Journal of virology, ISSN 0022-538X, 2015, Volume 89, Issue 14, pp. 7224 - 7234
Life Sciences & Biomedicine | Science & Technology | Virology | Influenza A Virus, H1N1 Subtype - immunology | Influenza A Virus, H5N1 Subtype - enzymology | Orthomyxoviridae Infections - prevention & control | Influenza Vaccines - administration & dosage | Influenza A Virus, H5N1 Subtype - genetics | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Influenza A Virus, H7N9 Subtype - immunology | Spodoptera | Sf9 Cells | Baculoviridae | Female | Influenza A Virus, H1N1 Subtype - genetics | Disease Models, Animal | Vaccines, Synthetic - genetics | Recombinant Proteins - genetics | Influenza A Virus, H3N2 Subtype - immunology | Cross Reactions | Animals | Influenza Vaccines - immunology | Influenza Vaccines - genetics | Recombinant Proteins - immunology | Influenza A Virus, H1N1 Subtype - enzymology | Influenza A Virus, H5N1 Subtype - immunology | Mice, Inbred BALB C | Vaccines, Synthetic - administration & dosage | Genetic Vectors | Orthomyxoviridae Infections - virology | Index Medicus
Journal Article
Journal of Virology, ISSN 0022-538X, 09/2010, Volume 84, Issue 17, pp. 8433 - 8445
Life Sciences & Biomedicine | Science & Technology | Virology | Influenza A Virus, H5N1 Subtype - enzymology | Influenza A Virus, H2N2 Subtype - enzymology | Humans | Influenza A virus - genetics | RNA Replicase - metabolism | Virulence | Molecular Sequence Data | Influenza A Virus, H5N1 Subtype - genetics | Viral Proteins - metabolism | Influenza A virus - pathogenicity | Interferon-beta - genetics | Female | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Amino Acid Sequence | Influenza, Human - metabolism | RNA Replicase - genetics | Viral Proteins - chemistry | Down-Regulation | Mice, Inbred C57BL | Viral Proteins - genetics | Influenza A Virus, H1N1 Subtype - pathogenicity | Influenza A Virus, H2N2 Subtype - pathogenicity | Influenza A virus - enzymology | Host-Pathogen Interactions | Sequence Alignment | Animals | Interferon-beta - metabolism | Influenza A Virus, H1N1 Subtype - enzymology | RNA Replicase - chemistry | Influenza, Human - genetics | Adaptor Proteins, Signal Transducing - genetics | Influenza A Virus, H2N2 Subtype - genetics | Protein Binding | Influenza A Virus, H5N1 Subtype - pathogenicity | Mice | Adaptor Proteins, Signal Transducing - metabolism | Index Medicus | Cellular Response to Infection
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 2015, Volume 21, Issue 1, pp. 136 - 141
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | United States - epidemiology | Antiviral Agents - pharmacology | Prevalence | Humans | Middle Aged | Drug Resistance, Viral | Neuraminidase - genetics | Viral Proteins - genetics | Influenza, Human - epidemiology | Male | Phylogeny | Influenza A Virus, H1N1 Subtype - drug effects | Young Adult | Influenza A Virus, H1N1 Subtype - enzymology | Adolescent | Adult | Female | Influenza, Human - virology | Influenza, Human - drug therapy | Influenza A Virus, H1N1 Subtype - genetics | Oseltamivir - pharmacology | Avian influenza | Oseltamivir phosphate | United States | Patient outcomes | Medical care | Forecasts and trends | Drug therapy | Index Medicus | influenza | influenza A(H1N1)pdm09 viruses | viruses | neuraminidase inhibition | Dispatch | pyrosequencing | resistance | Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14 | H275Y mutation | neuraminidase | influenza virus | zanamivir | oseltamivir
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 01/2020, Volume 221, Issue 1, pp. 63 - 70
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Thiepins - therapeutic use | Triazines - therapeutic use | Thiepins - pharmacology | Influenza A Virus, H3N2 Subtype - genetics | Viral Proteins - metabolism | Lung - virology | Madin Darby Canine Kidney Cells | Inhibitory Concentration 50 | Female | Influenza A Virus, H1N1 Subtype - genetics | Orthomyxoviridae Infections - drug therapy | Oxazines - pharmacology | Pyridines - therapeutic use | Virus Replication - drug effects | Antiviral Agents - pharmacology | Triazines - pharmacology | Influenza A Virus, H3N2 Subtype - enzymology | RNA-Dependent RNA Polymerase - genetics | Antiviral Agents - therapeutic use | Influenza A Virus, H3N2 Subtype - pathogenicity | Mice, Inbred C57BL | Pyridones | RNA-Dependent RNA Polymerase - metabolism | Viral Proteins - genetics | Influenza A Virus, H1N1 Subtype - pathogenicity | Morpholines | Drug Resistance, Viral - genetics | Phenotype | Animals | Influenza A Virus, H1N1 Subtype - enzymology | Oxazines - therapeutic use | Dogs | Dibenzothiepins | Mice | Pyridines - pharmacology | Mutation | Viral Load - drug effects | Orthomyxoviridae Infections - virology | Amino Acid Substitution | Polymerase chain reaction | Oseltamivir | Cell culture | Influenza | Virulence | Viruses | Influenza A | Experiments | Fitness | Mutants | Index Medicus | Abridged Index Medicus | influenza | Major and Brief Reports | A(H3N2) | I38T | A(H1N1)pdm09 | baloxavir | resistance
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2008, Volume 52, Issue 9, pp. 3284 - 3292
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Viral diseases of the respiratory system and ent viral diseases | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Cell Line | Influenza B virus - enzymology | Antiviral Agents - pharmacology | Influenza A Virus, H3N2 Subtype - enzymology | Global Health | Influenza A Virus, H3N2 Subtype - drug effects | Antiviral Agents - therapeutic use | Oseltamivir - therapeutic use | Humans | Drug Resistance, Viral | Neuraminidase - genetics | Influenza, Human - epidemiology | Influenza A Virus, H3N2 Subtype - genetics | Influenza A Virus, H1N1 Subtype - drug effects | Influenza B virus - genetics | Animals | Influenza A Virus, H1N1 Subtype - enzymology | Influenza, Human - virology | Neuraminidase - antagonists & inhibitors | Influenza B virus - drug effects | Seasons | Influenza A Virus, H1N1 Subtype - genetics | Population Surveillance | Oseltamivir - pharmacology | Index Medicus | Antiviral Agents
Journal Article
Journal of general virology, ISSN 0022-1317, 03/2016, Volume 97, Issue 3, pp. 620 - 631
Influenza A Virus, H1N1 Subtype - immunology | Influenza A Virus, H7N9 Subtype - physiology | Influenza Vaccines - administration & dosage | Influenza A Virus, H5N1 Subtype - physiology | Humans | Influenza A Virus, H1N1 Subtype - physiology | Influenza A Virus, H5N1 Subtype - genetics | Ovum - virology | Influenza A Virus, H3N2 Subtype - genetics | Viral Proteins - metabolism | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Influenza A Virus, H9N2 Subtype - genetics | Viral Proteins - genetics | Influenza, Human - epidemiology | Chick Embryo | Hemagglutinin Glycoproteins, Influenza Virus - metabolism | Animals | Influenza Vaccines - immunology | Influenza Vaccines - genetics | Virus Replication | Influenza A Virus, H1N1 Subtype - enzymology | Influenza A Virus, H3N2 Subtype - physiology | Influenza A Virus, H7N9 Subtype - genetics | Influenza, Human - prevention & control | Influenza A Virus, H9N2 Subtype - physiology | Index Medicus
Journal Article
Journal of Virology, ISSN 0022-538X, 09/2012, Volume 86, Issue 17, pp. 9221 - 9232
Life Sciences & Biomedicine | Science & Technology | Virology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Miscellaneous | Microbiology | Pandemics | Receptors, Virus - metabolism | Swine Diseases - virology | Humans | Neuraminidase - genetics | Viral Proteins - metabolism | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Swine | Neuraminidase - chemistry | Polysaccharides - chemistry | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Influenza A Virus, H1N1 Subtype - metabolism | Hemagglutinin Glycoproteins, Influenza Virus - chemistry | Influenza, Human - metabolism | Orthomyxoviridae Infections - metabolism | Orthomyxoviridae Infections - veterinary | Viral Proteins - chemistry | Swine Diseases - metabolism | Neuraminidase - metabolism | Viral Proteins - genetics | Influenza, Human - epidemiology | Hemagglutinin Glycoproteins, Influenza Virus - metabolism | Polysaccharides - metabolism | Animals | Receptors, Virus - chemistry | Influenza A Virus, H1N1 Subtype - enzymology | Protein Binding | Kinetics | Orthomyxoviridae Infections - virology | Index Medicus | Virus-Cell Interactions
Journal Article
Archives of virology, ISSN 0304-8608, 12/2014, Volume 159, Issue 12, pp. 3269 - 3278
Medical Microbiology | Infectious Diseases | Biomedicine | Virology | Life Sciences & Biomedicine | Science & Technology | Influenza A Virus, H3N2 Subtype - drug effects | Influenza A Virus, H1N1 Subtype - physiology | Flavonoids - therapeutic use | Microbial Sensitivity Tests | Lung - virology | Madin Darby Canine Kidney Cells | Inhibitory Concentration 50 | Flavonoids - pharmacology | Cell Culture Techniques | Orthomyxoviridae Infections - drug therapy | Disease Models, Animal | Antiviral Agents - pharmacology | Lung - pathology | Influenza A Virus, H3N2 Subtype - enzymology | Antiviral Agents - therapeutic use | Enzyme Inhibitors - pharmacology | Treatment Outcome | Viral Proteins - antagonists & inhibitors | Influenza A Virus, H1N1 Subtype - drug effects | Enzyme Inhibitors - therapeutic use | Enzyme Inhibitors - isolation & purification | Virus Release - drug effects | Administration, Intravenous | Animals | Influenza A Virus, H1N1 Subtype - enzymology | Dogs | Survival Analysis | Neuraminidase - antagonists & inhibitors | Scutellaria - chemistry | Flavonoids - isolation & purification | Influenza A Virus, H3N2 Subtype - physiology | Mice | Antiviral Agents - isolation & purification | Antiviral agents | Dosage and administration | Health aspects | Analysis | Mortality | Influenza | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 06/2008, Volume 453, Issue 7199, pp. 1258 - 1261
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Antiviral agents | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Influenza A Virus, H5N1 Subtype - enzymology | Humans | Molecular Conformation | Drug Resistance, Viral | Neuraminidase - genetics | Crystallography, X-Ray | Influenza A Virus, H5N1 Subtype - genetics | Oseltamivir - chemistry | Enzyme Inhibitors - chemistry | Neuraminidase - chemistry | Influenza, Human - virology | Binding Sites | Influenza A Virus, H1N1 Subtype - genetics | Oseltamivir - pharmacology | Enzyme Inhibitors - metabolism | Enzyme Inhibitors - pharmacology | Models, Molecular | Neuraminidase - metabolism | Zanamivir - pharmacology | Influenza A Virus, H5N1 Subtype - drug effects | Influenza A Virus, H1N1 Subtype - drug effects | Mutation - genetics | Oseltamivir - metabolism | Influenza A Virus, H1N1 Subtype - enzymology | Protein Binding | Neuraminidase - antagonists & inhibitors | Kinetics | Influenza viruses | Properties | Microbial mutation | Proteins | Enzymes | Hydrogen bonds | Amino acids | Mutation | Drug resistance | Avian flu | Crystal structure | Index Medicus
Journal Article